Acquisition of Properties

The MedicX Fund Limited 27 December 2006 For immediate release 27 December 2006 MedicX Fund Limited ('MedicX Fund', 'the Fund' or 'the Company') Acquisition of Twelve New Properties MedicX Fund, the specialist investor in modern purpose built primary healthcare properties which listed on the Official List of the London Stock Exchange on 2 November 2006, today announces that it has completed the acquisition of a further 11 new properties, nine of which have already been built with two under construction and due to complete in May and October 2007. The properties are currently owned by Medcentres 2006 Limited ('Medcentres 2006') which will be acquired by MedicX Fund for £10.3 million from NJ Arnold. Medcentres 2006 has debt net of cash of £26.3 million and a working capital balance of £0.6 million. In addition, MedicX Properties I Ltd (a subsidiary of the Fund) has contracted to acquire a property in Wisbech for £6 million directly from NJ Arnold. The aggregate purchase price is £16.3 million with £15.8 million in cash and £510,000 in MedicX Fund shares issued at a price of £1.02 per share paid to NJ Arnold. The two projects under construction require a further £4.2m to complete; the total cost of the 12 acquired properties when all are complete is therefore £46.2m before purchaser costs. Medcentres 2006 Limited will be renamed MedicX Properties IV Ltd. The Fund will refinance the existing debt using its £100 million loan from Norwich Union at its 5% fixed total borrowing cost. The 12 properties are located in Rugby, Norwich, Braintree, Gravesend, Lymington, Ringwood, Wareham, March, Bridport, Evesham, Verwood and Wisbech. The current rent of the 12 properties is £2,789,783 per annum in aggregate and the properties have been valued by DTZ Debenham Tie Leung, valuers to the MedicX Fund, at £49.6 million net of 5.75% purchaser costs. The current rent and valuation assumed the two under construction are completed. The 12 new sites bring the total number of primary healthcare properties owned by the MedicX Fund to 34. In addition, the MedicX Group has secured an exclusive option to forward fund new properties developed by NJ Arnold and Medcentres until 1 January 2009 which can be extended with the agreement of both parties. This acquisition was not included in the pipeline reported in the Medicx Fund IPO prospectus but is in line with the strategy of the business. Keith Maddin, Chairman of MedicX Group, said: 'We are delighted to have finished the year on such a positive note. In our first two months the MedicX Fund has assembled a portfolio of 34 modern primary healthcare properties spread across England and Wales. The £67.8 million invested (before purchaser costs and on top of the £46 million initial portfolio) in new properties exceeds the target assumed for the first twelve months presented in the prospectus and has been valued by DTZ at £74.3 million. The Fund's pipeline has been enhanced following the recent transactions with Oakapple and Medcentres. We look forward to 2007 and the further opportunities that may arise.' End For further information please contact: MedicX Group +44(0) 1252 704 272 Keith Maddin, Chairman Mike Adams, Managing Director Buchanan Communications +44 (0) 20 7466 5000 Charles Ryland / Lisa Baderoon / Mary-Jane Johnson This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings